These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 16447272)

  • 1. Apoptosis and necrosis in the liver: a tale of two deaths?
    Malhi H; Gores GJ; Lemasters JJ
    Hepatology; 2006 Feb; 43(2 Suppl 1):S31-44. PubMed ID: 16447272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of tumor necrosis factor-alpha receptor 1 and tumor necrosis factor-related apoptosis-inducing ligand-(TRAIL) receptor-2/DR-5, but not Fas, in graft injury in live-donor liver transplantation.
    Tashiro H; Itamoto T; Ohdan H; Arihiro K; Tateaki Y; Nakahara H; Ochi M; Hino H; Mizunuma K; Hara H; Tokita D; Onoe T; Ishiyama K; Mitsuta H; Sugino K; Asahara T
    Transpl Int; 2004 Nov; 17(10):626-33. PubMed ID: 15502938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family.
    Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S
    Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP-depleting carbohydrates prevent tumor necrosis factor receptor 1-dependent apoptotic and necrotic liver injury in mice.
    Latta M; Künstle G; Lucas R; Hentze H; Wendel A
    J Pharmacol Exp Ther; 2007 Jun; 321(3):875-83. PubMed ID: 17369282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Death receptors in chemotherapy and cancer.
    Debatin KM; Krammer PH
    Oncogene; 2004 Apr; 23(16):2950-66. PubMed ID: 15077156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting death receptors in bladder, prostate and renal cancer.
    O'Kane HF; Watson CJ; Johnston SR; Petak I; Watson RW; Williamson KE
    J Urol; 2006 Feb; 175(2):432-8. PubMed ID: 16406966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review).
    Gupta S
    Int J Oncol; 2003 Jan; 22(1):15-20. PubMed ID: 12469180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection by cyclosporin A of mitochondrial and cellular functions during a cold preservation-warm reperfusion of rat liver.
    Plin C; Haddad PS; Tillement JP; Elimadi A; Morin D
    Eur J Pharmacol; 2004 Jul; 495(2-3):111-8. PubMed ID: 15249159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of small molecules that sensitize resistant tumor cells to tumor necrosis factor-family death receptors.
    Schimmer AD; Thomas MP; Hurren R; Gronda M; Pellecchia M; Pond GR; Konopleva M; Gurfinkel D; Mawji IA; Brown E; Reed JC
    Cancer Res; 2006 Feb; 66(4):2367-75. PubMed ID: 16489043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular signaling mechanisms of acetaminophen-induced liver cell death.
    Jaeschke H; Bajt ML
    Toxicol Sci; 2006 Jan; 89(1):31-41. PubMed ID: 16177235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Death receptor-mediated liver injury.
    Akazawa Y; Gores GJ
    Semin Liver Dis; 2007 Nov; 27(4):327-38. PubMed ID: 17979070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
    Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM
    J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
    Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
    Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular survival pathways in the liver.
    Luedde T; Trautwein C
    Liver Int; 2006 Dec; 26(10):1163-74. PubMed ID: 17105581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.
    Beraza N; Lüdde T; Assmus U; Roskams T; Vander Borght S; Trautwein C
    Gastroenterology; 2007 Jun; 132(7):2504-17. PubMed ID: 17570222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell death in response to antimetabolites directed at thymidylate synthase.
    Barbour KW; Berger FG
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):189-201. PubMed ID: 17396263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
    Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T
    Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L).
    Guseva NV; Rokhlin OW; Taghiyev AF; Cohen MB
    Breast Cancer Res Treat; 2008 Feb; 107(3):349-57. PubMed ID: 17453339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of acetaminophen induced mitochondrial dysfunctions and hepatic necrosis via Akt-NF-kappaB pathway: role of a novel plant protein.
    Ghosh A; Sil PC
    Chem Biol Interact; 2009 Jan; 177(2):96-106. PubMed ID: 18835260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.